Enhanc3D Genomics: Daniel Turner

Enhanc3D Genomics, a company specializing in 3D genome mapping tools, has appointed Daniel Turner as CSO. Turner joins the company from Oxford Nanopore Technologies, where he held roles including senior VP, VP, and senior director of applications. He has also served as head of sequencing technology development at the Wellcome Trust Sanger Institute after postdoctoral positions at Wellcome Sanger and Weill Cornell Medical College. He holds a biochemistry degree from the University of Oxford and completed an MSc and PhD in genetics at the University of Manchester Institute of Science and Technology.